Rosuvastatin 10mg + Clopidogrel 75mg Capsule in PCD pharma franchise in Hyderabad

Rosuvastatin 10mg + Clopidogrel 75mg Capsule in pharmaceutical manufacturing company in Mumbai

Rosuvastatin 10mg + Clopidogrel 75mg Capsule in cardiovascular pharma franchise in Pune

Rosuvastatin 10mg + Clopidogrel 75mg Capsule in pharma suppliers in Delhi

Rosuvastatin 10mg + Clopidogrel 75mg Capsule in pharma export companies in Kolkata
Rosuvastatin 10mg + Clopidogrel 75mg Capsule in pharma franchise opportunities in Bengaluru

Home/Products /rosuvastatin-10-mg-clopidogrel-75-mg-tablet

About the Product

Description


Rosumore CV 10/75 Capsule combines Rosuvastatin 10mg and Clopidogrel 75mg, formulated to offer dual cardiovascular protection. Rosuvastatin is a statin that works by lowering bad cholesterol (LDL) and triglycerides while increasing good cholesterol (HDL). Clopidogrel is an antiplatelet agent that prevents platelets from clumping together, reducing the risk of blood clots. This combination helps prevent heart attacks, strokes, and other complications in patients with a history of cardiovascular disease or risk factors like diabetes, hypertension, and high cholesterol.

Common side effects may include headache, dizziness, muscle pain, stomach discomfort, or nausea. In rare cases, serious effects like liver dysfunction, myopathy, or bleeding tendencies may occur. Patients should report unusual bruising, muscle weakness, or yellowing of the skin immediately.

This capsule is indicated for the secondary prevention of atherosclerotic events such as myocardial infarction and stroke in patients with existing coronary artery disease, peripheral vascular disease, or cerebrovascular disorders. It is also prescribed to manage dyslipidemia and reduce the progression of atherosclerosis in high-risk patients.

Use under medical supervision only. Do not self-medicate or discontinue abruptly. Inform your doctor of any history of bleeding disorders, liver impairment, or concurrent use of other blood thinners. Regular lipid profile and liver function tests are advised during prolonged therapy.

Store in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

1. What are the business opportunities for Rosuvastatin 10 mg + Clopidogrel 75 mg Capsule in the PCD pharma franchise market?

Rosuvastatin 10 mg + Clopidogrel 75 mg Capsule is a cardiovascular combination therapy used for the prevention and management of heart attack, stroke, atherosclerosis, and other cardiovascular conditions associated with high cholesterol and blood clot formation. Rosuvastatin helps lower LDL (bad cholesterol), while Clopidogrel acts as an antiplatelet agent to reduce the risk of blood clots. This combination is widely prescribed by cardiologists, physicians, and cardiac care specialists, making it a high-potential product in the PCD pharma franchise and chronic cardiac care market.

2. Why should medical distributors include this product in their range?

Medical distributors and wholesalers can benefit from the consistent demand for cardiovascular risk management therapies. This combination is commonly prescribed for long-term use in patients with coronary artery disease and other cardiac conditions, ensuring regular repeat prescriptions, stable monthly sales, and strong demand from hospitals and retail pharmacies.

3. Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiovascular and cardiac care segment, including Rosuvastatin 10 mg + Clopidogrel 75 mg Capsule. We provide monopoly rights, quality-assured manufacturing, promotional support, and reliable product availability to help franchise partners grow successfully in the cardiac care market.

4. What benefits do wholesalers get by partnering for this product?

Wholesalers and stockists benefit from strong prescription-based demand, long-term patient dependency, and widespread acceptance among cardiologists and physicians. As cardiovascular disease management often requires continuous therapy, this product ensures steady product movement, repeat business opportunities, and sustainable profitability in pharmaceutical distribution.

5. How can I become a distributor or franchise partner for Rosuvastatin 10 mg + Clopidogrel 75 mg Capsule?

Medical distributors, stockists, and pharma professionals interested in cardiovascular and cardiac care products can contact Cafoli Lifecare to discuss pricing, availability, monopoly franchise rights, and PCD pharma franchise opportunities. We provide complete support through marketing materials, dependable supply chains, and territory-based business assistance to help partners expand their pharmaceutical business.